OurCrowd Backs CytoReason in $80 Million Funding Round
Online investment platform OurCrowd has invested in CytoReason as part of an $80 million funding round. OurCrowd joined a group of big names in supporting the firm as NVIDIA, Pfizer, and Thermo Fisher all participated in the funding round. Bank Hapoalim was said to have… Read More
Read more in: Artificial Intelligence, Global, Offerings | Tagged cytoreason, israel, ourcrowd